Fundraising FoxFrazier Life Sciences — 2015 Investments
11 investments dated 2015 · listed companies and verified rows first · show all
AnaptysBio manages the financial collaborations from Jemperli (with GSK) and imsidolimab (with Vanda), operating a virtual model focused on protecting and returning royalty and milestone value to stockholders.
BiotechSan Diego, US
Robert Hoffman(Executive Officer)inMarco Londei(Executive Officer)inHamza Suria(Executive Officer, Director)inDaniel Faga(President, CEO, and Director)inChristopher Murphy(CFO)
BoardCarol Gallagher(Director)
Board seatJames N. Topper· per SEC Form D
Co-investorsBioBritBiotechnology Value FundNorwest Venture PartnersNovo Holdings
Collegium Pharmaceutical is a biopharmaceutical company developing a portfolio of medications to treat serious medical conditions.
BiotechCanton, US
Michael Heffernan(Executive Officer, Director)inPaul Brannelly(Executive Officer)inVikram Karnani(President and Chief Executive Officer, and Director)in
BoardEran Nadav(Director)John Freund(Director)
Board seatPatrick Heron· per SEC Form D
Co-investorsAPERTURE Venture PartnersEcoR1 CapitalLongitude CapitalBoston Millennia PartnersRA Capital
Pharmaceutical company developing medicines and vaccines for patient health and treatment.
BiotechHealthtechSan Diego, US
Jeffrey Stein(Executive Officer, Director)Kevin Judice(Director)inKevin Forrest(Executive Officer)Dirk Thye(Executive Officer)inKen Bartizal(Executive Officer)inPaul Daruwala(Executive Officer)in
Board seatPatrick Heron· per SEC Form D
Co-investors5AM VenturesAisling CapitalBain Capital Life SciencesRA CapitalVivo CapitalCanaan Partners+1 more
Rocket Pharmaceuticals develops gene therapies to treat patients with rare genetic diseases, focusing on cardiovascular and hematologic disorders.
BiotechDigital HealthMedical Devices
Gaurav Shah(Co-founder & Chief Executive Officer)in
BoardRoderick Wong(Director)inNaveen Yalamanchi(Director)in
Co-investorsAvoro Capital AdvisorsBroadview VenturesCivilization Ventures Management, LlcLifeSci Venture PartnersRTW Investments L.P.
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Allena PharmaceuticalsChanRxEBH HoldingMerganser BiotechNexcida TherapeuticsSilvergate PharmaceuticalsIgnyta
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.